CDC Study Shows Flu Vaccine Reduces Risk of Death in Children
A new study conducted by the Centers for Disease Control and Prevention shows that during the years 2010 through 2014, the influenza vaccine reduced the risk of flu-associated death by half among children with underlying high-risk medical conditions and by nearly two-thirds among healthy children.
Flu Vaccine May Cause Immune-Related Adverse Events with Checkpoint Inhibitors
Study results from the division of oncology at University Hospital Basel in Switzerland show that patients treated with PD-1/PD-L1 checkpoint inhibitors may be at an increased risk for adverse events after receiving the seasonal influenza vaccination.
Adult Vaccines: A Needed Boost
Suboptimal adult vaccination rates are spurring increased awareness and efforts to improve access to important vaccines.
Pertussis Vaccine in Pregnancy Protects Nine of 10 Newborns from Whooping Cough
A new study shows newborns of pregnant women who have gotten their pertussis booster vaccine are far less likely to get
the disease than other babies.
New Rotavirus Vaccine Is More Protective in Children
A new vaccine to protect against rotavirus has been developed by Serum Institute of India.
U.S. Vaccine Supply: Understanding and Combating Shortages
Vaccine shortages do occur, but plans are in place to help mitigate them and to lessen their impact on both public and private sectors.
Vaccine in Development for Early-Stage Breast Cancer
Researchers at the Moffitt Cancer Center are developing a new vaccine that will help early-stage breast cancer patients who have HER2 positive disease.
Influenza: The Quest for a Universal Vaccine
Promising research is targeting the hemagglutinin protein to develop vaccines that could protect against all strains of the flu.
Coming Soon: A Highly Effective New Vaccine to Prevent Shingles
Approximately one million cases of shingles are reported annually in the U.S., and half of individuals over age 85 years are likely to develop shingles. The need for a vaccine that can provide protective immunity against shingles and PHN in older at-risk adults is clear.
C.Diff Vaccine Shows Promise in Phase II Trial
Results of a Phase II clinical trial ofPfizer’s preventive vaccine againstClostridium difficile (C. diff) showed the vaccine was safe and stimulated a C. diff targeted immune response.